Misoprostol
In brief
- In our pharmacy, you can buy misoprostol without a prescription, with delivery in 9–21 days throughout the United Kingdom. Discreet and anonymous packaging.
- Misoprostol is used for gastric ulcer prevention in NSAID users, medical abortion (usually with mifepristone), miscarriage management, labour induction and prevention/treatment of postpartum haemorrhage; it is a prostaglandin E1 analogue that protects gastric mucosa and causes cervical ripening and uterine contractions by acting on prostaglandin receptors.
- Usual doses vary by indication: gastric protection 200 mcg 2–4 times daily; medical abortion 800 mcg (4×200 mcg) buccal/vaginal/sublingual after mifepristone 200 mg; miscarriage management commonly 800 mcg vaginally (may repeat after 3–12 h); labour induction 25 mcg vaginally every 4–6 h (off‑label in many areas); postpartum haemorrhage 600–800 mcg orally as a single dose.
- Form of administration: tablets (standard 200 mcg, occasionally 100 mcg), given orally, sublingually, buccally or vaginally depending on indication; combination tablets with diclofenac are marketed for NSAID gastroprotection.
- Onset time depends on route: sublingual/buccal ~15–30 minutes, oral ~20–30 minutes, vaginal ~30–60 minutes (vaginal route yields slower onset but more sustained uterine effect).
- Duration of action: systemic half‑life is short (around 20–40 minutes), but clinical effects—particularly uterine contractions—may persist for several hours (commonly 3–6 hours); gastric protective dosing is given regularly while at risk.
- Avoid or minimise alcohol while taking misoprostol as it may worsen gastrointestinal side effects and dehydration; avoid alcohol if using for pregnancy‑related indications.
- The most common side effect is diarrhoea.
- Would you like to try misoprostol without a prescription?
Basic misoprostol information
- INN (international nonproprietary name): Misoprostol
- Brand names available in the United Kingdom: Cytotec and generic misoprostol tablets; Arthrotec (combination with diclofenac).
- ATC code: A02BB01 (gastric protection); G02AD06 (gynaecological use)
- Forms and dosages: Tablets 200 mcg (standard); 100 mcg (less common); combination tablets with diclofenac (Arthrotec) pairing 200 mcg misoprostol with diclofenac.
- Manufacturers in the United Kingdom: Pfizer (Cytotec) and generic manufacturers
- Registration status in the United Kingdom: Prescription-only medicine (POM)
- OTC / Rx classification: Prescription-only medicine (POM).
Critical warnings and restrictions
Who needs extra caution?
Misoprostol is a prescription-only medicine with important safety considerations for UK patients.
Absolute contraindications include known hypersensitivity to prostaglandins and pregnancy when the tablet is being used for gastric protection.
Exceptions to pregnancy contraindication exist only when the medicine is used deliberately within clinician-supervised medical abortion or miscarriage protocols.
- High-risk groups (require closer oversight):
- Elderly and frail older people (higher risk of GI side effects).
- Pregnant or potentially pregnant people — confirm pregnancy location to exclude ectopic pregnancy.
- People with prior uterine surgery, especially multiple caesarean sections.
- Those with inflammatory bowel disease or chronic diarrhoea.
- Severe cardiovascular disease or uncontrolled asthma.
- Severe hepatic or renal impairment.
- Documentation checklist for dispensing:
- Confirm pregnancy status and record result.
- Document history of uterine surgery, caesarean sections and obstetric history.
- List current medicines, especially uterotonics, NSAIDs, cardiovascular agents and asthma treatments.
- Provide emergency contact details and clear red-flag guidance.
Interaction with activities
Common adverse effects such as dizziness, severe diarrhoea and uterine cramps can impair the ability to drive or operate heavy machinery.
Advise patients under the UK Highway Code and workplace safety regulations not to drive or perform hazardous work if they experience dizziness, blurred vision, fainting or severe cramping.
Pharmacists should record counselling on the dispensing label and in pharmacy notes when driving or workplace safety is discussed.
Q&A — Can I drive after taking it in the UK?
If you feel well and have no dizziness, severe diarrhoea or sedation, driving is normally safe.
If symptoms such as dizziness, fainting or severe cramping occur, stop driving immediately and seek help.
Report severe or unexpected reactions via the MHRA Yellow Card.
Usage basics
What misoprostol is called
- INN: Misoprostol.
- Common brand names: Cytotec; Arthrotec (combination with diclofenac); generic misoprostol.
Quick definitions
- POM: Prescription-only medicine.
- ATC: Anatomical Therapeutic Chemical classification; misoprostol is A02BB01 (and G02AD06 for gynaecological use).
- INN: International Nonproprietary Name — Misoprostol.
In the UK market, generics and branded Cytotec are obtained by prescription through NHS or private routes.
Packaging is typically 200 mcg tablets; 100 mcg preparations are less common.
Always verify the local brand and package via MHRA or local pharmacy databases before supply.
Dosing guide
Standard regimens (summary table)
| Indication | Dose | Route | Timing / repeat |
|---|---|---|---|
| Gastric ulcer prevention | 200 mcg | Oral | Two to four times daily with food and at bedtime |
| Medical abortion (with mifepristone) | 800 mcg (4 × 200 mcg) | Buccal / Vaginal / Sublingual | Given after mifepristone 200 mg per protocol (timing varies 24–48 h) |
| Miscarriage management | 800 mcg | Vaginal | Single dose; may repeat after 3–12 hours if indicated |
| Labour induction (specialist use) | 25 mcg | Vaginal | Every 4–6 hours per local protocol (off-label in many trusts) |
| Postpartum haemorrhage | 600–800 mcg | Oral | Single dose for PPH management |
Adjustments for comorbidities
No routine dose reduction is required for mild to moderate renal impairment.
Use caution in severe renal or hepatic impairment and monitor clinically.
Elderly patients are more prone to gastrointestinal side effects and should be monitored.
Avoid use where inflammatory bowel disease or chronic diarrhoea is present if alternatives exist.
For pregnancy-related uses follow specialist obstetric protocols and do not self-adjust doses for abortion or miscarriage.
Q&A — What if I miss a dose?
For ulcer prophylaxis take the missed dose as soon as you remember unless it is near the time for the next dose; do not double the next dose.
For abortion, miscarriage or induction protocols contact your provider immediately because timing is critical and doses must not be self-doubled.
Interaction chart
Food and drinks
- Take misoprostol with food to reduce gastrointestinal upset when used for gastric protection.
- Avoid alcohol while taking misoprostol as it may worsen nausea, vomiting and diarrhoea and increase dehydration risk.
- Caffeinated drinks may aggravate cramps or nausea for some people; advise on an individual basis.
- Practical advice: take with meals, avoid alcohol, stay hydrated, and monitor symptoms.
Common drug conflicts
| Co‑medication | Concern | Monitoring / action |
|---|---|---|
| Mifepristone | Used together in medical abortion; timing and route are protocolised | Follow clinical protocol; do not self‑prescribe |
| NSAIDs / Diclofenac | Some combination products exist (eg Arthrotec); watch for GI indications and interactions | Check indication; avoid unnecessary duplication; counsel on side effects |
| Oxytocics (oxytocin, ergometrine) | Additive uterine effect when given with misoprostol in obstetric settings | Use only under obstetric supervision |
| Cardiovascular drugs | Severe CVD may increase risk of hypotension or tachycardia with systemic prostaglandins | Monitor vitals and review risk/benefit |
- Checklist for suspected interaction:
- Review full medication list and recent prescriptions.
- Check indication and whether misoprostol is combined with NSAID in a product.
- Report suspected interactions or unexpected adverse events via the MHRA Yellow Card.
Legal status and availability in the UK
In our online pharmacy, misoprostol is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Mechanism and pharmacology
How misoprostol works — simple flow
Misoprostol is a prostaglandin E1 analogue that acts on mucosal and smooth muscle receptors.
In the stomach it increases mucus and bicarbonate secretion and reduces gastric acid secretion which protects the gastric lining from NSAID damage.
In reproductive tissues it stimulates uterine smooth muscle contraction and promotes cervical ripening which underlies its use in abortion, miscarriage management, labour induction and postpartum haemorrhage control.
Clinical terms
- ATC classification: A02BB01 (gastric protection); G02AD06 — prostaglandins for gynaecological use.
- Pharmacokinetics vs Pharmacodynamics:
- Pharmacokinetics describes absorption, distribution and elimination which vary by route.
- Pharmacodynamics describes effects on tissues such as gastric mucosa and uterine muscle.
- Routes: Oral gives systemic exposure and more GI upset; vaginal, buccal and sublingual routes are often used in obstetric protocols to enhance uterine exposure and alter onset/peak.
Indications and off‑label uses
MHRA‑approved uses
Misoprostol (Cytotec) is licensed for the healing and prevention of gastric and duodenal ulcers, including NSAID-associated ulcers, and is used in obstetric care under specialist protocols.
In UK practice prescribers follow MHRA and local Trust protocols when defining indication‑specific dosing and consent.
Off‑label practices in NHS and private care
- Common off‑label uses include labour induction using low‑dose vaginal regimens under local protocols.
- Management of missed or incomplete miscarriage using vaginal misoprostol is a common specialist practice.
- Use as part of combined medical abortion regimens (mifepristone + misoprostol) follows evidence-based protocols even where specific licences vary.
- Prescriber documentation checklist:
- Record indication and rationale for off‑label use in the patient notes.
- Obtain and document informed consent including explanation of known risks.
- Define monitoring and escalation pathways and provide written aftercare information.
Alternatives matrix
Comparison table — misoprostol versus alternatives
| Drug | Indication | Route | Onset | Advantages | Safety concerns |
|---|---|---|---|---|---|
| Misoprostol | Gastric protection, abortion, PPH, induction | Oral, vaginal, buccal, sublingual | 30–60 minutes (oral) depending on route | Stable tablet, multiple routes | GI upset; uterine effects; contraindicated in some pregnancies |
| Mifepristone | Medical abortion (usually combined) | Oral | Systemic; works prior to misoprostol | Increases effectiveness of medical abortion | Prescription/regulatory controls; requires protocol adherence |
| Dinoprostone | Labour induction, cervical ripening | Vaginal, intracervical | Varies; local effect | Well‑studied for induction | Often requires refrigeration |
| Oxytocin | PPH, labour augmentation | IV/IM | Rapid | Effective and standard in hospital settings | Parenteral administration; requires monitoring |
| Carboprost | PPH (injectable) | IM | Rapid | Powerful uterotonic for refractory PPH | Bronchospasm risk; not for uncontrolled asthma |
- Pros and cons checklist for prescribing:
- Misoprostol pros: tablet stability, multiple routes.
- Misoprostol cons: GI side effects, variable licensed indications, uterine risks in certain surgical histories.
- Consider mifepristone for combined medical abortion; consider dinoprostone or oxytocin where parenteral options are feasible.
Common questions
- How quickly does it work?
Onset depends on route; oral dosing may have systemic effects within 30–60 minutes.
Vaginal, buccal and sublingual routes used in obstetric care have differing absorption and clinical timings specified by clinicians.
- What are normal side effects?
Common effects include diarrhoea, abdominal pain, nausea and headache.
For reproductive uses expect uterine cramping and bleeding as part of the effect.
Seek help for fever, heavy bleeding, fainting or signs of infection.
- Can I use it while breastfeeding?
Short single‑dose use such as for postpartum haemorrhage is not generally contraindicated but discuss with the clinician for prolonged courses.
- Where do I report side effects?
Report suspected adverse reactions via the MHRA Yellow Card scheme at MHRA Yellow Card.
Also inform your prescriber or pharmacist so local records can be updated.
Registration and regulation
MHRA approval process
Misoprostol products such as Cytotec and generics are prescription-only medicines regulated in the UK by the MHRA.
Prescribers must use licensed indications or document robust off‑label justification and informed consent.
Adverse events and safety signals should be reported to MHRA via the Yellow Card scheme.
NHS prescribing framework
- Local Trust formularies define dosing, monitoring, and escalation pathways for obstetric uses.
- Pharmacists must perform medicine safety checks, provide counselling and ensure prescriptions align with local guidelines.
- Required documentation and reporting steps:
- Record indication and consent for off‑label use.
- Document counselling and safety advice in patient records.
- Report suspected adverse reactions to MHRA Yellow Card and local governance leads.
Storage and handling
Household storage in the UK
Store misoprostol below 25°C in a dry place away from humidity and heat.
Keep tablets in their original blister or bottle to protect them from moisture in UK homes which can have damp or variable heating cycles.
Avoid storing in bathrooms or kitchens where humidity is high and avoid refrigeration unless the product label instructs otherwise.
When travelling carry tablets in climate‑stable containers and avoid leaving them in hot cars.
- Storage and travel checklist:
- Keep in original packaging and note the expiry date.
- Store in a cool, dry cupboard away from sunlight.
- Return unused or expired medicines to a pharmacy for safe disposal; do not flush or bin.
Pharmacy handling
Pharmacists should inspect packaging before supply and advise patients on expiry, stability and correct storage.
Hospital storage will be secured and temperature‑monitored according to trust policy.
Guidelines for proper use
Pharmacist counselling style
Use a patient‑centred consultation to verify indication and pregnancy status prior to supply.
Review contraindications, comorbidities and concurrent medications and explain expected effects and red flags such as severe bleeding, fever or chest pain.
Provide written aftercare instructions and emergency contact numbers and document counselling in the patient record.
- Counselling checklist:
- Confirm pregnancy status and pregnancy location where relevant.
- Discuss common side effects and when to seek urgent care.
- Advise on activity restrictions (no driving if symptomatic) and provide MHRA Yellow Card information.
- Arrange or advise on follow‑up appointments as required.
NHS patient safety advice
Prescribers must ensure informed consent with documented escalation pathways for complications such as heavy bleeding, suspected sepsis or persistent severe pain.
In abortion or miscarriage care arrange follow‑up by telephone or in‑person, offer contraception counselling if requested and ensure clear emergency access.
Provide patient leaflets and links to MHRA and NHS guidance and advise Yellow Card reporting for adverse events.
Delivery across the United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | England | 9–21 days |
| Birmingham | England | 9–21 days |
| Manchester | England | 9–21 days |
| Leeds | England | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Bristol | England | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Newcastle | England | 9–21 days |
| Southampton | England | 9–21 days |
| Norwich | England | 9–21 days |
| Plymouth | England | 9–21 days |
| Brighton | England | 9–21 days |